Physician profile
Robin G Major
NPI 1689079212
$753.41
in general payments reported to CMS, 2019-2025
17 companies · $90.27 in 2025
The $90.27 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $418 · 2022: $137 · 2023: $62.81 · 2024: $45.43 · 2025: $90.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $296.97 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $49.76 | 2022 | |
| Novo Nordisk INC | $49.74 | 2024-2025 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $45.23 | 2023 | |
| Ferring Pharmaceuticals INC. | $44.82 | 2021 | |
| Catalyst Orthoscience | $39.41 | 2021 | |
| Viiv Healthcare Company | $28.62 | 2025 | Apretude |
| Abbvie INC. | $28.01 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $27.01 | 2022 | |
| Orthofix Medical, INC. | $26.87 | 2022 | |
| Si-Bone, INC. | $19.92 | 2022 | |
| Kci USA, INC. | $19.76 | 2021 | |
| Bioventus LLC | $17.58 | 2023 | Bonescalpel |
| Endo Pharmaceuticals INC. | $16.64 | 2021 | |
| Edwards Lifesciences Corporation | $14.93 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.40 | 2024 | |
| Ethicon US, LLC | $13.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Major listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.